Forma Therapeutics Holdings Inc

NASDAQ:FMTX   3:59:27 PM EDT
40.61
+0.52 (+1.31%)
Earnings Announcements

Forma Therapeutics Reports Third Quarter 2020 Financial Results And Provides Business Update

Published: 11/12/2020 12:18 GMT
(FMTX) - Forma Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update.
Forma Therapeutics - Phase 1 Trial of Ft-7051 in Metastatic Castration-resistant Prostate Cancer on Track to Begin Enrolling Patients Before Year End.
Forma Therapeutics Holdings Inc Qtrly Loss per Share 67 Cents.
Revenue is expected to be $0.25 Million
Adjusted EPS is expected to be -$0.82

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.91

More details on our Analysts Page.